resultant striking increase in morbidity and mortality. The transition to symptomatic heart
failure is accompanied by further activation of neurohormonal and cytokine systems, as well …

In humans, the biological limitations to cardiac regenerative growth create both a clinical
imperative—to offset cell death in acute ischemic injury and chronic heart failure—and a …

PURPOSE The effective management of fistulas in patients with Crohn's disease presents
an extremely challenging problem. Mesenchymal adult stem cells extracted from certain …

Recent studies have suggested that bone marrow cells might possess a much broader
differentiation potential than previously appreciated. In most cases, the reported efficiency of …

Bone marrow mononuclear cells (BMCs) from 20 patients with extensive reperfused
myocardial infarction (MI) were used to assess their myocardial regenerative capability “in …

The association between leukocytosis and increased morbidity and mortality of ischemic
vascular disease has been observed for more than half a century, and recent studies in> …

Endothelial progenitor cells (EPCs) seem to be a promising tool for cell therapy of acute
myocardial infarction, but their nature is still unclear. We show here that EPCs obtainable …

Endothelial progenitor cells (EPCs) are involved in the maintenance of endothelial
homoeostasis and in the process of new vessel formation. Experimental and clinical studies …

Cardiomyocytes respond to physiological or pathological stress only by hypertrophy and not
by an increase in the number of functioning cardiomyocytes. However, recent evidence …

Background—Granulocyte colony-stimulating factor (G-CSF) treatment was shown to inhibit
neointimal formation of balloon-injured vessels, whereas neither the identification of …